Snyder Capital Management’s Core Laboratories CLB Stock Holding History

Snyder Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-442,315	Closed	-$20.6M	–	72
2019 Q3	$20.6M	Buy	+442,315	New	+$20.6M	0.9%	41
2018 Q3	–	Sell	-35,698	Closed	-$4.5M	–	72
2018 Q2	$4.5M	Buy	35,698 +2,396	+7%	+$292K	0.21%	62
2018 Q1	$3.6M	Sell	33,302 -683	-2%	-$75.6K	0.18%	62
2017 Q4	$3.72M	Buy	33,985 +2,013	+6%	+$201K	0.19%	61
2017 Q3	$3.16M	Sell	31,972 -5,261	-14%	-$510K	0.16%	61
2017 Q2	$3.77M	Buy	37,233 +1,950	+6%	+$210K	0.2%	59
2017 Q1	$4.08M	Buy	35,283 +15,444	+78%	+$1.79M	0.22%	59
2016 Q4	$2.38M	Sell	19,839 -1,077	-5%	-$119K	0.14%	60
2016 Q3	$2.35M	Hold	20,916	–	–	0.15%	64
2016 Q2	$2.59M	Sell	20,916 -147	-0.7%	-$17.7K	0.17%	61
2016 Q1	$2.37M	Hold	21,063	–	–	0.16%	60
2015 Q4	$2.29M	Hold	21,063	–	–	0.16%	60
2015 Q3	$2.1M	Hold	21,063	–	–	0.14%	65
2015 Q2	$2.4M	Sell	21,063 -547	-3%	-$66.3K	0.13%	63
2015 Q1	$2.26M	Buy	+21,610	New	+$2.3M	0.11%	62

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Snyder Capital Management's CLB Position: Q4 2019 in Review

Snyder Capital Management sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 442,315 shares — an estimated $20.6M sold.

Snyder Capital Management first reported a position in CLB in Q1 2015 and held it in 15 quarters. The position peaked at $20.6M in Q3 2019. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

Snyder Capital Management reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
Snyder Capital Management sold 442,315 Core Laboratories shares in Q4 2019, an estimated $20.6M.
Snyder Capital Management first reported a position in Core Laboratories in Q1 2015 and held it in 15 quarters.
Snyder Capital Management's Core Laboratories position peaked at $20.6M in Q3 2019.
283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Snyder Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.